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Abstract. This work summarizes the results of the largest skin image
analysis challenge in the world, hosted by the International Skin Imaging
Collaboration (ISIC), a global partnership that has organized the world’s
largest public repository of dermoscopic images of skin. The challenge
was hosted in 2018 at the Medical Image Computing and Computer As-
sisted Intervention (MICCAI) conference in Granada, Spain. The dataset
included over 12,500 images across 3 tasks. 900 users registered for data
download, 115 submitted to the lesion segmentation task, 25 submitted
to the lesion attribute detection task, and 159 submitted to the disease
classification task. Novel evaluation protocols were established, includ-
ing a new test for segmentation algorithm performance, and a test for
algorithm ability to generalize. Results show that top segmentation al-
gorithms still fail on over 10% of images on average, and algorithms with
equal performance on test data can have different abilities to generalize.
This is an important consideration for agencies regulating the growing
set of machine learning tools in the healthcare domain, and sets a new
standard for future public challenges in healthcare.
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1 Introduction
Skin cancer is the most common form of cancer in the United States, with the
annual cost of care exceeding $8 billion [1]. With early detection, the 5 year
survival rate of the most deadly form, melanoma, can be up to 99%; however,
delayed diagnosis causes the survival rate to dramatically decrease to 23% [2].
Due to the importance of early detection, much work has been dedicated to
increasing the accuracy and scale of diagnostic methods. In 2016 and 2017, the
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International Skin Imaging Collaboration (ISIC), a global partnership that has
organized the world’s largest repository of publicly available dermoscopic im-
ages, hosted the first public benchmarks for melanoma detection in dermoscopic
images, titled “Skin Lesion Analysis Towards Melanoma Detection”, at the IEEE
International Symposium of Biomedical Imaging (ISBI) [3,4,5]. The two consec-
utive challenges attracted global participation, with over 900 registrations and
over 350 submissions, making them the largest standardized and comparative
studies at the time, yielding novel findings and numerous publications, and have
been tacitly accepted as a de-facto reference standard by other groups [6,7,8,9].
This article describes the methods and the results from the most recent in-
stance of the ISIC Challenge on Skin Lesion Analysis Towards Melanoma De-
tection, hosted in 2018 at the Medical Image Computing and Computer Aided
Intervention (MICCAI) conference in Granada, Spain. In addition to consider-
able increases in the size of the dataset and number of diagnostic labels, key
changes to evaluation criteria and study design were implemented to better re-
flect the complexity of clinical scenarios encountered in practice. These changes
included 1) a new segmentation metric to better account for extreme deviations
from interobserver variability, 2) implementation of balanced accuracy for clas-
sification decisions to minimize influence of prevalence and prior distributions
that may not be consistent in practice, and 3) inclusion of external test data
from institutions excluded from representation in the training dataset, to better
assess how algorithms generalize beyond the environments for which they were
trained. The impacts of each change are examined in this work, followed by a
set of recommendations for future challenges.
2 Methods
The challenge was separated into 3 image analysis tasks of lesion segmentation,
attribute detection, and disease classification (Fig. 1). There was no require-
ment that any task be independent of the data or analytics developed for the
other tasks. Participants were required to provide 4-page manuscripts along with
submissions describing implemented methods. Participants were allowed to use
alternative sources of in-domain (dermoscopic) data, but were required to dis-
close such use in a specific meta-data field. Use of out-of-domain data (non-
dermoscopic), such as ImageNet, was expected to be mentioned in manuscripts,
but not required to be disclosed in a separate meta-data field.
2.1 Part 1: Lesion Segmentation
For Part 1, 2,594 dermoscopic images with ground truth segmentation masks
were provided for training. For validation and test sets, 100 and 1,000 images
were provided, respectively, without ground truth masks.
Evaluation criteria historically has been the Jaccard index [3,4,5], averaged
over all images in the dataset. In practice, ground truth segmentation masks are
influenced by inter-observer and intra-observer variability, due to variations in
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Fig. 1: Example training data and ground truth from Part 1: Lesion Segmenta-
tion, Part 2: Attribution Detection, and Part 3: Disease Classification.
human annotators and variations in annotation software [10]. An ideal evaluation
would generate several ground truth segmentation masks for every image using
multiple annotators and software systems. Then, for each image, predicted masks
would be compared to the multiple ground truth masks to determine whether the
predicted mask falls outside or within observer variability. However, this would
multiply the manual labor required to generate ground truth masks, rendering
such an evaluation impractical and infeasible.
As an approximation to this ideal evaluation criteria, we introduced “Thresh-
olded Jaccard”, which works similarly to standard Jaccard, with one important
exception: if the Jaccard value of a particular mask falls below a threshold T, the
Jaccard is set to zero. The value of the threshold T defines the point in which a
segmentation is considered “incorrect”.
Prior work measured the average Jaccard between 3 expert annotators on 100
images from the 2016 challenge [6]. The resulting values were 0.743, 0.754, and
0.861, yielding an average of 0.786 and a range of 0.118. For the 2018 challenge,
T was defined as 0.65, by rounding the lowest agreement to 0.75 and subtracting
one rounded range (0.10) to increase the certainty (specificity) of failure.
2.2 Part 2: Lesion Attribute Detection
For Part 2, 2,594 images with 12,970 ground truth segmentation masks for 5
attributes were provided for training. For validation and held-out test sets, 100
and 1,000 images were provided, respectively, without masks.
Jaccard was used as the evaluation metric this year in order to facilitate pos-
sible re-use of methods developed for segmentation, and encourage greater par-
ticipation. As some dermoscopic attributes may be entirely absent from certain
images, the Jaccard value for such attributes is ill-defined (division by 0). To
overcome this difficulty, the Jaccard was measured by computing the TP, FP,
and FN for the entire dataset, rather than a single image at a time.
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Fig. 2: Histograms of submissions for Part 1: Lesion Segmentation. Performance
on the X-axis, and number of submissions on the Y-axis. Average values shown
as solid vertical lines, and +/- standard deviation shown as dotted vertical lines.
2.3 Part 3: Lesion Disease Classification
For Part 3, 10,015 dermoscopic images with 7 ground truth classification labels
were provided for training [11]. For validation and held-out test sets, 193 and
1,512 images were provided, respectively, without ground truth.
Held-out test data was further split into two partitions: 1) an “internal” par-
tition, consisting of 1,196 images selected from data sources that were consis-
tent with the training dataset (two institutions in Austria and Australia), and
2) an “external” partition, consisting of 316 images additionally selected from
data sources not reflected in the training dataset (institutions from Turkey, New
Zealand, Sweden, and Argentina).
Evaluation was carried out using balanced accuracy (mean recall across classes
after mutually exclusive classification decision), because dataset prevalence may
not be reflective of real world disease prevalence, especially with regard to over-
representation of melanomas. Previous years had used melanoma average preci-
sion [3] and melanoma AUC (area under receiver operating characteristic curve),
which are only robust to the prevalence imbalance of melanomas, and may be
influenced by clinically irrelevant low-sensitivity performance.
3 Results
3.1 Part 1: Lesion Segmentation
In total, 112 submissions were received for Part 1. The top performing sub-
mission achieved a Thresholded Jaccard of 0.802, with many of the other top
algorithms also achieving approximately 0.8. A histogram summary of the sub-
missions are shown in Fig. 2, showing the proportion of failures (segmentations
below 0.65 Jaccard), performance according to Thresholded Jaccard, and perfor-
mance according to Jaccard. Supplemental Fig. 5 shows the histograms stratified
by disease type, and supplemental Table 1 shows details of the top 5 submissions.
What is clear from this analysis is that even though submissions may achieve
very high scores in average Jaccard values (over 0.8, exceeding even previous re-
ports of average Jaccard values for inter-observer variability of 0.786 [6]), most
methods still fail to properly segment over 10% of images (failures most common
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(a) A) (b) B)
Fig. 2: Assessment of new Threshold Jaccard metric. A) Proportion of segmenta-
tion failures (X-axis) vs. various metric values (Y-axis). B) Participant ranking
by Thresholded Jaccard (X-axis) vs. Jaccard (Y-axis).
Fig. 3: Histogram of submissions to Part 2: Lesion Attribute Detection.
for seborrheic keratoses). This is an important observation that is often diluted
by most aggregated statistics.
Fig. 2A shows the correlation between both Thresholded Jaccard and Jaccard
against the proportion of segmentation failures, demonstrating that Thresholded
Jaccard has a correlation slope closer to 1, suggesting that the new metric may be
a better assessment of clinical utility. Fig. 2B shows a scatter plot of participant
challenge rank according to Thresholded Jaccard (X-axis) and Jaccard (Y-axis),
demonstrating that changing the evaluation criteria to Threhsolded Jaccard has
an impact on the ranking of participant algorithms.
3.2 Part 2: Lesion Attribute Detection
In total, 26 submissions were received for Part 2. The histograms of performance
of each attribute is plotted in Fig. 3 according to average Jaccard. The distri-
bution of values were exceptionally low, with the best submissions achieving an
average of 0.473. Poor performance may be the result of several factors, which
may include that dermoscopic attributes tend to have poor inter-observer corre-
lation among expert clinicians [12]. The implications for future challenges may
be that either the field of clinical dermoscopic attributes must mature further
before additional research is performed to apply machine learning—or that ma-
chine learning methods should be applied to the reverse problem: to help find
and annotate specific patterns that may correlate strongly with disease.
6 Codella et al.
Fig. 4: Histograms of submissions for Part 3: Lesion Classification. Average values
showed as solid vertical lines, and +/- standard deviation showed as dotted
vertical lines. Left: Entire test dataset. Center: Internal (blue) and External
(green) test partitions split. Right: Histogram of the subtraction of external test
performance from internal.
3.3 Part 3: Lesion Disease Classification
In total, 141 submissions were received to Part 3. Histograms of submission
performance, according to balanced accuracy (BACC), are shown in Fig. 7. ROC
plots for the top 12 submissions are shown in Supplemental Fig. 6, details of top
5 submissions are shown in Supplemental Table 2, and histograms for AUC by
disease are shown in Supplemental Fig. 7. The highest performance achieved
was 0.885. Correlation between internal and external test dataset performance
for each submission is shown in Fig. 4A, and between whole test set performance
and the difference between internal and external sets in 4B. Differences in ranking
according to balanced accuracy, accuracy, and mean AUC are plotted in Fig. 4.
These analyses provide the following important observations: 1) Most submis-
sions overfit and perform better on internal data vs. external data (Fig. 7), but
some approaches, including the top performers, do not (Figs. 7 & 4B). 2) The
use of proprietary data is not required in order to prevent overfitting to internal
data (Fig. 4B). 3) Various algorithms may achieve similar whole test set perfor-
mance but vary widely on their ability to generalize (Fig. 4B). 4) Simple linear
correlation between internal and external test dataset performance does not elu-
cidate the spread of overfitting as clearly as plotting by the difference between
datasets (Fig. 4A vs. Fig. 4B). 5) The choice of evaluation metric has a signifi-
cant impact on participant ranking (Fig. 4). Use of balanced accuracy is critical
to select the best unbiased classifier, rather than one that overfits to arbitrary
dataset prevalence, as is the case with accuracy (Fig. 4A). Even other unbiased
estimators, such as mean AUC (Fig. 4B) show significant differences in rank as
compared to balanced accuracy, and consider areas of operating curves, such as
low-recall regions, that may not be clinically relevant.
4 Discussion & Conclusion
This work summarizes the results of the 2018 MICCAI Challenge on Skin Lesion
Analysis Toward Melanoma Detection, hosted by the International Skin Imag-
ing Collaboration (ISIC), which represents the de facto standard benchmark for
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(a) A) (b) B)
Fig. 4: Comparisons of participant performance on internal test dataset vs. ex-
ternal test dataset. A: Internal vs. external test set peformance. B: Whole test
set vs. the difference between internal and external test set performances.
(a) A) (b) B)
Fig. 4: Impact of new balanced accuracy (BACC) jaccard metric on participant
ranking. A) BACC vs. ACC. B) BACC vs. Mean AUC
machine learning in this domain. In total, over 12,500 images were made avail-
able for training across 3 tasks, and over 2,000 images for testing. 900 teams
registered, and 299 submissions were received, making this challenge the largest
in the field to date, in terms of size, complexity, and degree of participation.
Several changes in evaluation criteria were implemented in comparison to pre-
vious ISIC challenges to better reflect difficulties encountered in clinical prac-
tice. These include 1) Thresholded Jaccard, which severely penalizes segmen-
tations that fall outside an estimate of interobserver variability, 2) balanced
accuracy, which avoids encouraging classification systems from over-fitting po-
tential dataset imbalances, and 3) a dual-partition held-out test set, including
data sourced from institutions not reflected in the training dataset, to better
measure algorithm ability to generalize.
Results show that 1) Thresholded Jaccard better captures the proportion of
segmentation failures in comparison to Jaccard, 2) balanced accuracy leads to
significant changes in participant ranking versus other metrics that may be more
prone to imbalance or influence from clinically irrelevant ROC regions, 3) multi-
partition test sets containing data not reflected in training dataset are an ef-
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fective way to differentiate the ability of algorithms to generalize, and 4) poor
performance observed in Part 2 may imply that dermoscopic attributes mature
further before research is continued to apply machine learning.
Future challenges and regulatory agencies in medical imaging and dermoscopic
image analysis should consider the presented evaluation criteria to best quantify
algorithm performance, robustness, and ability to generalize in clinical scenarios.
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5 Supplementary Material
Fig. 5: Histograms of submissions for Part 1: Lesion Segmentation, stratified by
disease state. Performance on the X-axis, and number of submissions on the
Y-axis. Average values shown as solid vertical lines, and +/- standard deviation
shown as dotted vertical lines.
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ALL MEL SEBK NEVI
R F TJ J F TJ J F TJ J F TJ J
1 0.093 0.802 0.838 0.095 0.792 0.832 0.310 0.577 0.698 0.066 0.832 0.856
2 0.079 0.801 0.838 0.090 0.782 0.830 0.195 0.667 0.743 0.063 0.820 0.851
3 0.083 0.799 0.834 0.100 0.782 0.826 0.299 0.585 0.706 0.053 0.829 0.852
4 0.085 0.798 0.838 0.090 0.792 0.839 0.207 0.656 0.740 0.069 0.817 0.848
5 0.084 0.796 0.837 0.095 0.799 0.849 0.195 0.670 0.738 0.067 0.811 0.845
Table 1: Top 5 submissions to Part 1: Lesion Segmentation. ALL = Performance
on entire test set. MEL = Performance on Melanomas. SEBK = Performance
on Seborrheic Keratoses. NEVI = Performance on Benign Nevi. R = Rank. F
= Failure rate. TJ = Thresholded Jaccard. J = Jaccard.
Accuracy AUC
R ACC BACC MEL NV BCC AKIEC BKL DF VASC
1 0.851 0.885 0.949 0.979 0.997 0.987 0.974 0.992 1.000
2 0.850 0.882 0.946 0.981 0.997 0.985 0.977 0.990 1.000
ALL 3 0.827 0.871 0.948 0.978 0.996 0.981 0.971 0.986 0.999
4 0.896 0.856 0.959 0.983 0.995 0.995 0.990 0.987 0.999
5 0.884 0.845 0.945 0.974 0.992 0.988 0.969 0.982 0.998
1 0.841 0.875 0.945 0.978 0.997 0.986 0.969 0.992 1.000
2 0.842 0.875 0.941 0.980 0.997 0.983 0.972 0.993 0.999
INT 3 0.820 0.875 0.944 0.977 0.997 0.980 0.965 0.994 0.999
4 0.907 0.854 0.961 0.982 0.999 0.995 0.988 0.973 0.999
5 0.894 0.841 0.939 0.973 0.997 0.988 0.963 0.973 0.998
1 0.886 0.925 0.970 0.984 0.998 1.000 0.984 0.993 1.000
2 0.880 0.911 0.966 0.986 0.998 1.000 0.987 0.989 1.000
EXT 3 0.854 0.894 0.970 0.982 0.993 1.000 0.983 0.984 0.999
4 0.854 0.866 0.984 0.984 0.987 0.997 0.994 0.995 1.000
5 0.848 0.864 0.976 0.971 0.978 0.998 0.978 0.984 0.999
Table 2: Top 5 submissions to Part 3: Lesion Classification. ALL = Performance
on entire test set. INT = Performance on Internal Test Set. EXT = Performance
on External Test Set. R = Rank. ACC = Accuracy. BACC = Balanced Accuracy.
MEL = Melanoma. NV = Nevi. BCC = Basal cell carcinoma. AKIEC = Actinic
keratosis. BKL = Benign keratosis. DF = Dermatofibroma. VASC = Vascular
Lesion.
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Fig. 6: ROC plots of all 7 disease states for the top 12 performing submissions.
Thick solid lines represents entire test dataset. Thin solid lines represents internal
test split, and dotted thin lines represent external test splits. Submission rank
in row order.
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Fig. 7: Histograms of submissions for Part 3: Lesion Classification, according to
AUC for each disease category. Average values showed as solid vertical lines,
and +/- standard deviation showed as dotted vertical lines. Left Column: Entire
test dataset. Center Column: Internal (blue) and External (green) test partitions
split. Right Column: Histogram of the subtraction of external test performance
from internal.
